Thermo Fisher Scientific is expanding its global production capacity for vaccines, medicines, and biologic therapies.

Nationwide Children's Hospital is constructing a $100 million gene therapy manufacturing center in Columbus, Ohio.

Ultragenyx is planning to build a 100,000-sf gene therapy manufacturing facility in Bedford, Mass.

CPI began construction in October of 2020 on the Medicines Manufacturing Innovation Centre in Inchinnan in the United Kingdom.

Merck is constructing a $69 million facility for the production of high-potency active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) compounds.

Facility Logix, EwingCole, and Biggins Lacy Shapiro have launched Rapid Reshore & Development (RR&D) to provide turnkey p

Fujifilm Diosynth Biotechnologies broke ground in August of 2020 on the $55 million Advanced Therapies Innovation Center in College Station, Texas.

Codiak BioSciences is constructing a 12,000-sf clinical manufacturing center in Lexington, Mass.

CRISPR Therapeutics signed a full-building lease in July of 2020 for a 263,500-sf facility in Boston's Seaport district.

The Cell and Gene Therapy Catapult is planning to create the Manufacturing Innovation Centre in Braintree in the United Kingdom.